yourstate.us
Home / United States / 21 CFR
21 CFR 556.52

§ 556.52 Apramycin.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 556.52, § 556.52 Apramycin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87737
Permanent ID
ys:prov:87737@1
SHA-256
71e9abd7bc316792dcf380bd845e651d281e769b620647f2327e87aefeedb9f1

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Acceptable daily intake (ADI). The ADI for total residue of apramycin is 25 µg/kg of body weight per day. (b) Tolerances. The tolerance for apramycin (marker residue) is: (1) Swine. Kidney (target tissue): 0.1 ppm. (2) [Reserved] (c) Related conditions of use. See §§ 520.110 and 558.59 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.